Prevalence and characteristics of pruritus in patients treated with different dialysis modalities

  • Saša Vuksanović
  • Nina Adamov
  • Mario Balo
  • Jasna Trbojević Stanković
Keywords: hemodialysis, peritoneal dialysis, uremic pruritus

Abstract


Introduction: Uremic pruritus is a common symptom in patients with end-stage renal disease (ESRD). Intense pruritus can lead to uncontrollable scratching, impaired sleep, anxiety, depression, therefore significantly lowering patient’s life quality. Although the prevalence of uremic itch in patients on dialysis has declined over the time, it is still present in peritoneal dialysis (PD) and hemodialysis (HD) patients.

Aim: The aim of this study is to investigate the prevalence of pruritus in HD patients compared to PD patients, as well as possible differences in its presentation and correlation   with demographic and clinical characteristics of the population.

Material and methods: A total of 50 HD and 50 PD patients were included. Dialysis modality, patient demographic, clinical characteristics, and laboratory data were recorded. Data on the presence and duration of itching, skin dryness and scaling were obtained from a general itch questionnaire. The visual-analogue scale (VAS) and the 5-D itch scale were used for evaluation of pruritus.

Results: Pruritus was present in 42% of PD patients and 24% of HD patients (p=0,056), without statistically significant differences in the distribution and intensity of pruritus in patients on different dialysis modality. A significantly higher number of PD patients had dry (41 vs 31; p= 0.026) and scaling skin (31 vs 15; p = 0.001). PD patients with pruritus had significantly higher levels ​​of intact parathyroid hormone (iPTH) (386,57±302,29pg/mL vs 159,25±163,52pg/mL; p=0,033) and AST (23,84±11,36U/L vs 14,17±3,73U/L; p=0,002), while having significantly lower levels ​​of urea (18,78±7,60mmol/L vs 23,65±4,31mmol/L; p=0,028), creatinine (717,96±229,50μmol/L vs 940,06±207,57μmol/L; p=0,009) and potassium (4,17±0,63mmol/L vs 5,80±0,80mmol/L; p=0,000) in comparison to HD patients with pruritus.

Conclusion: Pruritus is a common symptom among ESRD patients treated with dialysis. In our study, a higher prevalence of pruritus was observed in PD patients. Dry skin and higher levels of​​ iPTH have been singled out as possible contributing factors to the occurrence of itch.

Keywords: hemodialysis, peritoneal dialysis, uremic pruritus

References

1. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)z. Kidney Int. 2005;67:2089–100.
2. Zazzeroni L, Pasquinelli G, Nanni E, Cremonini V, Rubbi I. Comparison of Quality of Life in Patients Undergoing Hemodialysis and Peritoneal Dialysis: A Systematic Review and Meta-Analysis. Kidney Blood Press Res. 2017;42:717–27.
3. Hu T, Wang B, Liao X, Wang S. Clinical features and risk factors of pruritus in patients with chronic renal failure. Exp Ther Med. 2019;964–71.
4. Kfoury LW, Jurdi MA. Uremic pruritus. J Nephrol. 2012;25:644–52.
5. Mettang T, Kremer AE. Uremic pruritus. Kidney Int. 2015;87:685–91.
6. Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69:1626–32.
7. Ponticelli C, Bencini PL. Uremic pruritus: A review. Nephron. 1992;60:1–5.
8. Gilchrest BA, Stern RS, Steinman TI, Brown RS, Arndt KA, Anderson WW. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol. 1982;118:154–6.
9. Wu HY, Huang JW, Tsai WC, Peng YS, Chen HY, Yang JY, et al. Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: A prospective cohort study. PLoS One. 2018;13:1–12.
10. Reszke R, Szepietowski JC. End-Stage Renal Disease Chronic Itch and Its Management. Dermatol Clin. 2018;36:277–92.
11. Min JW, Kim SH, Kim YO, Jin DC, Song HC, Choi EJ, et al. Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis. Kidney Res Clin Pract. 2016;35:107–13.
12. Wu HY, Peng YS, Chen HY, Tsai WC, Yang JY, Hsu SP, et al. A comparison of uremic pruritus in patients receiving peritoneal dialysis and hemodialysis. Med (United States). 2016;95:1–6.
13. Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: Evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92:497–501.
14. Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: A new measure of pruritus. Br J Dermatol. 2010;162:587–93.
15. Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21:3495–505.
16. Ozen N, Cinar FI, Askin D, Mut D. Uremic pruritus and associated factors in hemodialysis patients: A multi-center study. Kidney Res Clin Pract. 2018;37:138–47.
17. Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis. Nephrol Dial Transplant. 2004;19:2709–12.
18. Sedighi O, Makhlough A, Kashi Z, Zahedi M. Relationship between serum parathyroid hormone and hypertension in hemodialysis patients. Iran J Kidney Dis. 2011;5:267–70.
19. Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y. Superior dialytic clearance of β2-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis. Kidney Int. 2006;70:794–9.
Published
2020/09/15
Section
Original Scientific Paper